Parkinson's Disease Flashcards
Clinical diagnostic features for PD
- Rest tremor
- rigidity
- Bradykinesia/ Akinesia
(± postural reflexes decreased - imbalance)
2 of the 3 features are required for diagnosis 1 of the 2 has to be bradykinesia
Definition of bradykinesia (in PD)
Slowness of movement AND decrement in amplitude or speed (or progressive hesitations/halts) as movements are continued.
Fatiguing in PD vs non PD movement disorders
In parkinsonism caused by PD, a decline in either speed or amplitude is seen as movements are continued, a feature sometimes not observed in parkinsonism caused by alternate conditions.
Non-Motor Sx PD
3 stages of early PD
- Preclinical PD
- neurodegenerative processes have commenced, but there are no evident symptoms or signs - Prodromal PD
- symptoms and signs are present, but are yet insufficient to define disease - Clinical PD
- diagnosis of PD based on presence of classical motor signs
Main RFs for PD
Smoking
FHx
Age
Major prodromal features of PD
- RBD (REM sleep behaviour disorder)
- hyposmia
- anxiety
- constipation
Diagnosis of REM sleep Behaviour Disorder
- movements of the body or limbs associated with dreaming
- plus at least one of the following:
– potentially harmful sleep behaviour
– dreams that appear to be acted out
– sleep behaviour that disrupts sleep continuity
What are Lewy bodies made of
alphasynuclein (alpha-SN) and several other proteins
Anatomical progression of PD
advances in an orderly sequence, starting in the medulla and the olfactory bulb, then spreads upwards to substantia nigra, then finally into the cortex
AE of levodopa
Nausea
Orthostatic hypotension
Confusion , Hallucinations
Sleepiness and sleep attacks
Motor fluctuations and dyskinesia
Impulse control disorders - worsens
Anti-emetics in PD
Use domperidone or ondansetron
Avoi:
metoclopramide, prochlorperazine
Issues with ergot dopamine issues
cardiac/lung/retroperitoneal fibrosis
Unavailability
Just use no-ergot derivatives
Nonergot dopamine agonists
apomorphine (subcutaneous)
pramipexole
ropinirole
rotigotine (transdermal)
piribedil
Dopamine agonist AE
Nausea
Orthostatic hypotension
- worse than with
Dopamine agonist AE
Nausea
Orthostatic hypotension
- worse than with levodopa
Confusion and hallucinations
Sleepiness and sleep attacks
Peripheral oedema, ankle swelling, facial oedema
Skin irritation/rash – Rotigotine (10%)
Impulse control disorders
- higher propensity than levodopa
Features of impulse control disorders
- Pathological gambling (more in males)
- Hypersexuality
- Compulsive (binge) eating
- Compulsive shopping (more in females)
Punding
stereotyped repetitive behaviours
Often associated with marked dyskinesias and off-state dysphoria and with over-use of levodopa
compulsive performance of repetitive, mechanical tasks, such as assembling and disassembling, collecting, or sorting household objects
Punding
stereotyped repetitive behaviours
Often associated with marked dyskinesias and off-state dysphoria and with over-use of levodopa
compulsive performance of repetitive, mechanical tasks, such as assembling and disassembling, collecting, or sorting household objects
MAO inhibitor examples in PD
- Selegiline
- Rasagiline
Good/ Bad aspects of each PD drug class in early PD
Levodopa
- well tolerated and most effective/potent
- Increased short-term dyskinesia rate with levodopa but no difference long-term
Dopamine agonists
– medium potency, less well tolerated, less dyskinesia
MAOI-B’s
- very well tolerated, low potency, low dyskinesia
Timing of dyskinesias with levodopa
Peak dose
* 30-60 min post Ldopa
* Chorea
* entire body/upper half
* Often not aware
End of dose
* 3-4 hours post Ldopa or early morning
* Dystonia
* Often foot
* Often painful
Management PEAK dose dyskinesia with levodopa
- reduce levodopa dose size
- add amantadine
- add dopamine agonist and reduce levodopa
- stop entacapone
Management END of dose dyskinesia with levodopa
- add entacapone or selegiline
- decrease dose interval
- increase levodopa dose size
- add amantadine
- add dopamine agonist